8635 W. 3rd St. Suite #485-W
Los Angeles, CA 90048
(310) 652-9162

Ravi Sharad Lakdawala, M.D.


Education and Training

2008 B.A., Medical Sciences – Cum Laude
Minor in Economics
Boston University
Boston, MA
2011 Doctor of Medicine
Boston University School of  Medicine
Boston, MA
2011-2012 Internship - Internal Medicine
Boston University/ Boston Medical Center
Boston MA
2012-2014 Residency – Internal Medicine
Boston University/ Boston
Medical Center
Boston, MA
2014-2016 Fellowship - Nephrology
LAC+USC Medical Center
Los Angeles, CA

Licensure and Certification

  1. Medical Board of California Licensure: 2014
  2. American Board of Internal Medicine Certification: 2014

Memberships in Professional Societies

  1. American Society of Nephrology
  2. National Kidney Foundation

Honors

Ariel Weisman Teaching Award
Outstanding Achievement in Clinical Teaching
Boston University Medical Campus


Clinical Study Location

Tower Nephrology Medical Group, 8635 West 3rd Street Suite 485W Los Angeles, CA 90048

DaVita of Beverly Hills, 50 N. La Cienega Blvd. #300 Beverly Hills, CA 90211

DaVita of Crescent Heights, 8151 Beverly Blvd Los Angeles, CA 90048


Clinical Studies

Sub-Investigator *2016 ICH Good Clinical Practice for Clinical Trail Sites (Certificates)
Sub-Investigator 2016 A Phase 3 Randomized, Open-Label (Sponsor-Blind), Active-Controlled, Parallel-Group, Multi-Center, Event Driven Study in Dialysis Subjects with Anemia Associated with Chronic Kidney Disease to Evaluate the Safety and Efficacy of Daprodustat Compared to Recombinant Human Erythropoietin, Following a Switch from Erythopoietin- Stimulating Agents.
Sub-Investigator 2016 A Phase 3, Prospective, Multicenter, Double-Blind, Randomized, active Control Study to Demonstrate the Safey and Effectiveness of Neutrolin in Preventing Catheter-Related Bloodstream infections in Subjects receiving Hemodialysis Therapy as treatment for End Stage Renal Disease
Sub-Investigator 2016 Phase 3, Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy and Safety of Oral Vadadustat for the Maintenance Treatment of Anemia in Subjects with Non-Dependent Chronic Kidney Disease (NDD-CKD) (Pro2tect – Conversion)
2014   Quality Improvement Research
Developed, studied, and executed a process to improve the transition from the inpatient setting to the affiliated outpatient dialysis unit for
dialysis patients at LAC+USC Medical Center. LAC+USC Medical Center, Los Angeles, CA
2012   Quality Improvement Research Developed, studied, and executed a process to decrease the time to first  antibiotic administration for septic patients in the inpatient wards at Boston Medical Center. Presented to the Boston Medical Center Department of Medicine and the Quality Improvement Department. Boston Medical Center, Boston, MA

Publications

  1. Lakdawala RS and Abdelmalek JA. “IgA Nephropathy.” Medicine Morning Report: Beyond the Pearls. Ed. Dasgupta R and Koolaee RM. (Pending book publication, September 2015)
  2. Lakdawala RS and Abdelmalek JA. “Nephrolithiasis.” Medicine Morning Report: Beyond the Pearls. Ed. Dasgupta R and Koolaee RM. (Pending book publication, September 2015)
  3. Campese VC and Lakdawala RS. “The Challenges of Blood Pressure Control in Dialysis Patients.” Clinical Dialysis. Ed. Nissenson AR and Fine RN. (Pending book punlication, 2015)

Abstracts and Presentations

  1. Lakdawala RS, Wachterman M. Symptomatic Anemia Due to Gastric Invasion of Hepatocelluar Carcinoma. Oral Presentation at Senior Research Academic Day, Boston University School of Medicine; 2014 June 6; Boston, MA
  2. Ghaffari A, Lakdawala RS. “Peritoneal Dialysis Solution Shortage: A Short-term Management Strategy.” Presented at Quality Improvement Slide Forum at Annual Dialysis Conference; 2015 Feb 2; New Orleans, CA.

Volunteer Experience

2012-2014 Peer Mentor
Boston University Internal Medicine Residency Program Boston, MA
2012-2014 Developer- Internal Medicine Intern Handbook
Boston University Internal Medicine Residency Program
Boston, MA

Languages

  1. English – Fluent written and spoken
  2. Spanish –Fluent written and spoken
  3. Gujarati – Conversational